Evoke Pharma (NASDAQ:EVOK) Stock Passes Below 50 Day Moving Average – Here’s What Happened

Evoke Pharma, Inc. (NASDAQ:EVOK) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $4.84 and traded as low as $4.45. Evoke Pharma shares last traded at $4.60, with a volume of 8,296 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on Evoke Pharma in a research note on Tuesday. They issued a “sell” rating on the stock.

Evoke Pharma Stock Performance

The business’s 50-day moving average is $4.79 and its 200-day moving average is $5.17. The company has a market capitalization of $6.84 million, a PE ratio of -0.42 and a beta of 0.15.

Institutional Trading of Evoke Pharma

An institutional investor recently bought a new position in Evoke Pharma stock. Corsair Capital Management L.P. acquired a new stake in shares of Evoke Pharma, Inc. (NASDAQ:EVOK) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,667 shares of the specialty pharmaceutical company’s stock, valued at approximately $56,000. Corsair Capital Management L.P. owned about 1.42% of Evoke Pharma at the end of the most recent quarter.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.